InnovAge (INNV)
(Real Time Quote from BATS)
$4.15 USD
+0.13 (3.11%)
Updated May 29, 2024 02:18 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
InnovAge Holding Corp. (INNV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.75 | $7.00 | $6.50 | 67.49% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for InnovAge Holding Corp. comes to $6.75. The forecasts range from a low of $6.50 to a high of $7.00. The average price target represents an increase of 67.49% from the last closing price of $4.03.
Analyst Price Targets (2 )
Broker Rating
InnovAge Holding Corp. currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on four recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/7/2024 | William Blair | Jared Haase | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 4 |
Average Target Price | $6.75 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 96 of 252 |
Current Quarter EPS Est: | -0.02 |